Cynthia Melinda Boyd, M.D., M.P.H.

• Professor of Medicine

https://www.hopkinsmedicine.org/profiles/results/directory/profile/0007719/cynthia-boyd

Steatohepatitis and progressive fibrosis are extremely uncommon in these disorders medications bad for kidneys discount risperidone 4 mg online. In early Wilson disease the liver typically shows patchy steatosis and many glycogenated nuclei medicine xyzal best 4 mg risperidone. The overall pattern of injury in Wilson disease is that of chronic hepatitis treatment research institute buy 2 mg risperidone otc, not steatohepatitis medicine jokes buy risperidone uk. Lipoprotein metabolism disorders such as abetalipoproteinaemia symptoms zinc toxicity 2 mg risperidone purchase mastercard, familial hypobetalipoproteinaemia, Dorfman­Chanarin syndrome and pseudoneonatal adrenoleucodystrophy have all been associated with the development of macrovesicular steatosis of the liver. Other inherited metabolic disorders are associated with microvesicular steatosis (see Table 5. Vitamin E has also been evaluated as a therapeutic agent because of its antioxidant properties. It is likely that additional, liver-directed therapies will become available within the next few years. Paradoxically, portal chronic inflammation may be increased in otherwise improved biopsies. B, the same patient was rebiopsied 2 years later; there had been no interventional therapy in the interim, but loss of steatosis. Bruchstück Med Jahrb des kaisl, königl Österr Staates 1839; Bd 29 oder neueste Folge Bd 20 Wien: 557. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. Post-jejunoileal-bypass hepatic disease: its similarity to alcoholic hepatic disease. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Patterns of chemotherapyinduced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. Similarities and differences in the pathogenesis of alcoholic and non-alcoholic steatohepatitis. Biochemical analysis of hepatic lipid in alcoholic and diabetic and control subjects. A staining method for the detection and measurement of fat droplets in hepatic tissue. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Accumulation of nascent lipoproteins in rat hepatic Golgi during induction of fatty liver by orotic acid. Impaired mitochondrial function in microvesicular steatosis: effects of drugs, ethanol, hormones and cytokines. Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. The liver in ferrous sulphate poisoning: a report of three fatal cases in children and an experimental study. Focal glycogenosis of the liver in disorders of ureagenesis: its occurrence and diagnostic significance. Familial Reye-like syndrome: a presentation of medium-chain acyl-coenzyme A dehydrogenase deficiency. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. Multiple hepatic mitochondrial deletions suggest premature oxidative ageing in alcoholic patients. Focal fatty change of the liver: a review and a case associated with continuous ambulatory peritoneal dialysis. Fatty macroregenerative nodule in non-steatotic liver cirrhosis: a morphologic study. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease. Correlation between liver morphology and portal pressure in alcoholic liver disease. Expression of perilipin and adipophilin in nonalcoholic fatty liver disease: relevance to oxidative injury and hepatocyte ballooning. Indian childhood cirrhosis: the nature and significance of cytoplasmic hyaline of hepatocytes. Focal nodular hyperplasia of the liver with alcoholic hyalin bodies and cytologic atypia. Hepatocellular hyalin (Mallory bodies) in long term griseofulvin-treated mice: a new experimental model for the study of hyalin formation. In vitro demonstration of Mallory body formation in liver cells from rats fed diethylnitrosamine. Mallory bodies: isolation of hepatocellular hyalin and electrophoretic resolution of polypeptide components. Pathology of cytoskeleton of liver cells: demonstration of Mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes. Mallory bodies: immunohistochemical detection by antisera to unique non-prekeratin components. Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic 87. Mallory bodies in alcoholic and non-alcoholic liver disease contain a common antigenic determinant. The genetic background modulates susceptibility to mouse liver Mallory­Denk body formation and liver injury. Gender dimorphic formation of mouse Mallory­Denk bodies and the role of xenobiotic metabolism and oxidative stress. A cell culture system for the induction of Mallory bodies: Mallory bodies and aggresomes represent different types of inclusion bodies. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease. Hepatocyte apoptosis and fas expression are prominent features of human non-alcoholic steatohepatitis. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in non-alcoholic fatty liver disease. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Cirrhosis mortality and per capita consumption of distilled spirits, United States, 1949­94: trend analysis. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Genetic and acquired factors that influence individual susceptibility to alcohol-associated liver disease. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Morphometric characteristics of human hepatocellular peroxisomes in alcoholic liver disease. Effects of chronic ethanol treatment and thyroxine administration on ethanol metabolism and liver oxidative capacity. Purification and characterization of a unique isozyme of cytochrome P450 from liver microsomes of ethanol-treated rabbits. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes. The role of lipid metabolism in the pathogenesis of alcoholic and non-alcoholic hepatic steatosis. Peroxisome proliferatoractivated receptor alpha protects against alcohol-induced liver damage. Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats. Betaine decreases hyperhomocysteinemia, endoplasmic reticulin stress, and liver injury in alcohol-fed mice. Dissection of endoplasmic reticulum stress signalling in alcoholic and non-alcoholic liver injury. The effects of chronic ethanol consumption on hepatic mitochondrial energy metabolism. Potentiation by chronic ethanol treatment of the mitochondrial permeability transition. Role of oxidative stress and antioxidant therapy in alcoholic and non-alcoholic liver diseases. Enhancement by glutathione depletion of ethanol-induced acute hepatotoxicity in vitro and in vivo. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives. Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. IgA deposition in liver in alcoholic liver disease: an index of progressive injury. IgA triggers tumor necrosis factor alpha secretion by monocytes: a study in normal subjects and patients with alcoholic cirrhosis. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanolinduced liver injury in mice. Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease. Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in antibody formation among alcoholics. Cytochromes P450 f2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. Impaired oxygen utilization: a new mechanism for the hepatotoxicity of ethanol in sub-human primates. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Fatty acid composition of liver total lipids in alcoholic patients with and without liver damage. Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Increased susceptibility of women to alcoholic liver disease: artifactual or real Risk of fatty infiltration or cirrhosis of the liver in relation to ethanol consumption: a case-control study. Changing pattern of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity. Histological course of alcoholic hepatitis: influence of abstinence, sex and extent of hepatic damage. High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey.

Nodular regenerative hyperplasia of the liver associated with the toxic oil syndrome: report of five cases symptoms xanax treats buy risperidone uk. Association between blood concentration of polychlorinated biphenyls and manifestations of symptoms 398 medicine 8 soundcloud risperidone 2 mg buy line. Mortality after exposure to polychlorinated biphenyls and polychlorinated dibenzofurans: a 40-year follow-up study of Yusho patients treatment endometriosis order risperidone with american express. Cocaine-induced liver cell injury: comparison of morphological features in man and in experimental models treatment 4 sore throat purchase genuine risperidone on-line. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option medicine park cabins 4 mg risperidone purchase fast delivery. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage. The effects of phencyclidine pretreatment on cocaine-mediated hepatotoxicity in mice. Long-term trends in the use of complementary and alternative medical therapies in the United States. Veno-occlusive disease of liver with nonportal type of cirrhosis, occurring in Jamaica. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeletonassociated protein thiols and forms plasma membrane blebs in rat hepatocytes. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Acute cholestatic hepatitis caused by Teucrium polium (golden germander) with transient appearance of antimitochondrial antibody. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Characterization of rat liver proteins adducted by reactive metabolites of menthofuran. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum Thunb. Acute hepatitis induced by ShouWu-Pian, a herbal product derived from Polygonum multiflorum. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido. Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases. Acute liver failure after administration of herbal tranquilizer kava-kava (Piper methysticum). In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Acute liver failure associated with the use of herbal preparations containing black cohosh. Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Subacute cholestatic hepatitis likely related to the use of senna for chronic constipation. N-acetylcysteine for the treatment of clove oil-induced fulminant hepatic failure. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Vitamin A abuse: development of cirrhosis despite cessation of vitamin A-a six-year clinical and histopathologic follow-up. Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults: report of two cases. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Hepatocanalicular injury associated with vitamin A derivative etretinateL an idiosyncratic hypersensitivity reaction. Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin). Fulminant hepatic failure following overdose of the vitamin A metabolite acitretin. Abnormal serum transaminase levels after parenteral ampicillin and carbenicillin administration. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Hepatitis associated with amoxycillin-clavulanic acid combination: report of 15 cases. Delayed drug-induced hepatic injury: evoking the role of amoxicillin-clavulinic acid combination]. Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid. Liver injury related to amoxicillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature. Risk of hepatotoxicity associated with fluoroquinolones: a national case-control safety study. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. Stevens-Johnson syndrome (erythema multiforme) following ingestion of trimethoprim-sulfamethoxazole on two separate occasions in the same person: a case report. Sulfonamide hepatic injury: review of the literature and report of a case due to sulfamethoxazole. Trimethoprim-sulfamethoxazole-associated hepatotoxicity: part of a hypersensitivity syndrome. Successful orthotopic liver transplantation after trimethoprim-sulfamethoxazole associated fulminant liver failure. Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim-sulfamethoxazole. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Serious adverse reactions induced by minocycline: report of 13 patients and review of the literature. Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data. Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases. Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms. Brief communication: severe hepatotoxicity of telithromycin-three case reports and literature review. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Under-reporting and poor adherence to monitoring guidelines for severe cases of isoniazid hepatotoxicity. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection. Severe hepatotoxicity associated with rifampin-pyrazinamide preventative therapy requiring transplantation in an individual at low risk for hepatotoxicity. Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine. Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. Acute hepatitis induced by alpha-interferon, associated with viral clearance, in chronic hepatitis C. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha. Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C. Drug-induced immunoallergic hepatitis during combination therapy with daclatasvir and asunaprevir. Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C. Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis. Trimethoprimsulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective randomized trial. Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines. Mechanism, pathology, and clinical presentation of hepatotoxicity of anesthetic agents. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury.

Microcystscanbepresent medicine go down order discount risperidone on line,aretypicallylinedbyflattened Other benign biliary-like lesions Ciliated hepatic foregut cyst is a rare lesion that might be clinically mistaken for a biliary cyst treatment 1st degree heart block generic 3 mg risperidone mastercard. The glands are variable in size and shape and admixed with fibroinflammatory stroma symptoms 7 days after ovulation buy risperidone now. Focally medications definitions buy risperidone 3 mg overnight delivery, the lining cells can be more crowded and more columnar than those in biliary hamartoma symptoms nervous breakdown cost of risperidone. These cysts are usually surrounded by bundles of smooth muscle, mimicking bronchi, and haveanouterfibrouscapsule. Riskformalignancyisverylow,but rare squamous carcinomas have been reported to arise in ciliated hepatic foregut cysts. Microcystic adenomas, or serous cystadenomas, are lesions that typically arise in the tail of the pancreas, but rarely they have also been described in the liver. These cysts lack the cellular mesenchymal stroma characteristic of mucinous cystic neoplasms. Bilomas contain bilious debris surrounded and admixed with inflammatory cells; bacterial overgrowth can occur. Xanthomatous change (macrophages with foamy, sometimes pigmented appearance) and an exuberant fibrous reaction are often present surrounding the lesion, which can mimic a tumour or an encapsulated lesion on imaging. They usually present with complications of biliary obstruction in adults and are only rarely seen in children. Resection is the standard therapy, but complete resection can be difficult to attain because of the multifocality of these tumours; recurrence is thus frequent. Another serious complication is the transformation to invasive adenocarcinoma, so the lesions must be generously sampled to examine for this risk. The epithelial lining consists of ciliated, pseudostratified columnar cells, similar to those seen in bronchial epithelium. High magnification demonstrates the cuboidal bland epithelium with clear cytoplasm. The intrahepatic ducts are filled with papillary fronds with fibrovascular stalks lined by columnar cells. A three-dimensional, slender, branching papillary structure shows a central stromal core covered by layers of dysplastic epithelial cells. The cells show indistinct cytoplasm, round to oval nuclei, nuclear contour irregularities and small nucleoli. Edgesoffragmentsmayshow columnar cells with basal nuclei and pale apical cytoplasm. Whenthere is malignant transformation, the appearances are those of adenocarcinoma. Lesions usually present due to a palpable mass, abdominalpain or discomfort, obstruction (with jaundice), rupture or infectious complications. Imaging can demonstrate the typical large multilocular cysts, but distinguishing benign lesions from those with invasive adenocarcinoma is often not possible. Thus, complete excision is recommended, with thorough histological examination for grading the lesion and excluding malignant transformation, a change more often seen in the high-grade lesions but still a rareoccurrence. It has been suggested that the mesenchymal stroma resembles the primitive mesenchyme of the embryonic gallbladder and large bile ducts, indicating a possible origin from embryonic foregut rests. Rarely,however,theymayarise associated with a bile duct and protrude into the bile ducts, leading to obstructive features. In all the variants, the involved ducts can be filled with these growths and thus are variably dilated. Frank invasion into the lamina propria of the stalk or bile duct wall is necessary for the diagnosis of an associated invasive adenocarcinoma. The cysts are lined by tall, columnar, mucinous epithelium overlying a compact ovarian-like stroma. A cohesive cluster of malignant glandular cells is seen surrounding a blob of mucin. Inthelow-tointermediategrade subtype, cell nuclei are usually bland and basally located, without mitotic activity. However, nuclear pleomorphism, loss of polarity, presence of mitotic figures and multilayering of the epithelium indicate a high-grade subtype, and for these lesions, more extensive examination should be done for invasive adenocarcinoma. The cytological diagnosis often is limited to either benign cyst contents or adenocarcinoma. Microcystic serous cystadenomas are multilocular lesions but are extremely rare in the liver (see earlier) and are lined by flattened or clear cells without ovarian-like stroma. Proliferative changes not considered dysplastic can also be seen in the intrahepatic biliary tree (see Chapter 9). For example, a variety of fibroinflammatory changes, such as chronic inflammation, epithelial hyperplasia, pseudopyloric metaplasia, hyperplasia of peribiliary glands and mucus acini, and fibrosis can be seen in the bile ducts as part of chronic proliferative cholangitis in association with conditions such as hepatolithiasis and liver fluke. These subtypes differ not only in their location, clinically and in overall outcome, but also regarding the cell of origin, epidemiology and molecular features. Histologically, however, the features are similar among tumours arising in any of the sites, and there is close resemblance to ductal adenocarcinoma of the pancreas, as part of pancreatobiliary adenocarcinomas. Although occasional cases occur in young people, the mean age is in the seventh decade, and the tumour occurs slightly more often in men. Tumour markers are usually not helpful in diagnosis due to a lack of specificity and overlap with benign conditions. The tumour cells form cords and focal glandular forms with somewhat irregular spacing and separation by fibrous stroma. In the periductal-infiltrating type the tumour has a similar appearance as the mass-forming type but infiltrates along the portal tracts with compression of involved ducts. Mucin, which may be demonstrable with special stains, is seldom abundant, except in the mucinous variant. There is high propensity for lymph node metastasis with thisfeature,presentin40­50%ofpatientsatinitialsurgery. Glands are well formed and lined by columnar to cuboidal cells with increased nuclear/cytoplasmic ratio. Nuclei are not highly variable, but there is irregular crowding, and small nucleoli are uniformly present. Histological subtypes the recognized variants include mucinous, signet ring cell, clear cell, adenosquamous, mucoepidermoid, lymphoepithelioma-like, and sarcomatoid(spindlecell)carcinomas. Asquamouscomponentis usually associated with a high-grade adenocarcinoma,528 whereas pure squamous cell carcinoma is rare and may be associated with chronic cholangitis. Mucoepidermoid carcinomas are extremely rare and have been reported in association with Thorotrast exposure and hepatic cyst. Thetumour cells in the sarcomatoid variant can be spindle or pleomorphic cells, and osteoclast-like giant cells can be present. Sheets of glandular epithelium with peripheral palisading nuclei and branching with tapered-off columns indicate bile ductal origin. Honeycomb sheets of cuboidal or columnar epithelial cells show round to eccentric nuclei, fine chromatin, small to inconspicuous nucleoli and ample, lacy or vacuolated cytoplasm. Microacinarformationandlarge cells with irregular nuclear membranes and prominent nucleoli may beevident. Signetring-typecellswithintracytoplasmic mucin vacuoles, extracellular mucinous pools and papillarystructuresmaybeseen. Various degrees of dysplasia and carcinoma in situ change may be appreciated across large flat sheets of biliary epithelium. Biliary tract brushing has emerged as the method of choice in the evaluation of biliary strictures. Thesensitivity of biliary brushing for diagnosis of malignant biliary strictures, however, ranges from only 30% to 88%, with almost 100% specificity. The tumour cells invade along and replace the cell plates and entrap remnant liver cells (pigmented cells in centre), imparting an anastomosing pattern of chains of cells. A, Tumour shows a focal glandular pattern consistent with cholangiocarcinoma, admixed with an intense lymphoplasmacytic inflammatory response as well as some neutrophilic reaction within the glandular epithelium (haematoxylin and eosin [H&E] stain). The uniform cells have well-defined cell borders, pale cytoplasm, oval nuclei with delicate chromatin, normal nuclear/cytoplasmic ratio and inconspicuous nucleoli. There is abrupt cell and nuclear enlargement with increased nuclear/cytoplasmic ratio, nuclear contour irregularities, hyperchromasia and prominent nucleoli. Cytological reports can be classified as benign, atypical, suspicious or malignant. Malignancy can be recognizedassingleandsmall,three-dimensional(3D)clustersof tumour cells, moulding and cell-in-cell grouping, enlarged pleomorphic nuclei with irregular nuclear outlines, prominent nucleoli and increased nuclear/cytoplasmic ratio, a tendency to dispersal with single cells as well as tumour giant cells in poorly differentiated tumours and inflammatory and degenerative changes with necrotic debris. There are cuboidal to columnar cells with round or ovoid nuclei depending on view from end or side, delicate chromatin, one or two inconspicuous nucleoli, occasional cytoplasmic vacuoles and occasional stromal fragments containing small, spindly cells with darkly staining, elongated nuclei. There is nuclear atypia; isolated enlarged and hyperchromatic nuclei with small but conspicuous nucleoli and a variable inflammatory cell component in the background. Atypical epithelium may range from reactive to low-grade and high-grade dysplastic changes. Separation of high-grade dysplasia from overt malignancy is difficult in the absence of evidence of subepithelial stromal invasion. The clinician should exercise extreme caution and take a conservative approach in the presence of stones, flukes and inflammatory processes, or sometimes extrinsic pressure. The sheet of ductal epithelium shows disorderly growth pattern with nuclear moulding and overlapping. The cells show marked nuclear contour irregularities with nuclear folding and grooves, chromatin clumping, distinct nucleoli and increased nuclear/cytoplasmic ratio. Thereistypically nuclear enlargement, moulding and irregular nuclear outlines, chromatinclumping,nuclearcrowdingandhighnuclear/cytoplasmic ratio with a background of necrotic debris. In brush cytology specimens, the tumours are mostly moderately differentiated adenocarcinomas. Key malignant cytomorphological features are 3D micropapillae, anisonucleosis, nuclear contour irregularity, prominent nucleoli and high nuclear/cytoplasmic ratio. Squamousdifferentiation, signet ring cells and mucin secretion may be evident in the corresponding subtypes of bile duct carcinoma. A, Cohesive cluster of overlapping epithelial cells show anisonucleosis and high nuclear/ cytoplasmic ratio. The cells show anisonucleosis, nuclear contour irregularities, nuclear moulding, distinct nucleolus, chromatin clumping and high nuclear/cytoplasmic ratio. The most difficult situation is distinguishing orderly, low-grade adenocarcinoma from inflammatory or reactive epithelial atypia. A, Strip of columnar epithelium with basally oriented oval nuclei and supranuclear mucin secretion. There is nuclear overlapping with nuclear contour irregularities, hyperchromasia and high nuclear/cytoplasmic ratio. B, Three-dimensional cluster of pleomorphic epithelial cells shows nuclear overlapping, anisonucleosis, nuclear contour irregularities, hyperchromasia, high nuclear/cytoplasmic ratio and distinct nucleolus. C, Three-dimensional cluster of pleomorphic epithelial cells shows cell-in-cell grouping. Extrahepatic metastases are found at autopsy in about 75% of patients, with lymph nodes andlungs(74%),peritoneumandadrenals(20%),kidney(15%) andbone(13%)asthemostcommonsites. There is no single widely accepted regimen, but a combination of cisplatin and gemcitabine is often used as adjuvant therapy as well in patients with unresectable disease. The most important prognostic factors for resectable tumours are lymph node metastasis and status of surgical margins. Other adverse prognostic factors include bilobar distribution, poor differentiation, histological variants such as signet ring and sarcomatous carcinomas, perineural invasion and vascular invasion. Correlation with the clinical setting, endoscopic findings and imaging is necessary to confirm the diagnosis. Vascular tumours Cavernous haemangioma Clinical features Cavernous haemangioma is the most common primary liver tumour and is most often discovered as an incidental finding at surgery or autopsy. The stretching of Glisson capsule secondary to recurrent intralesional haemorrhages and organizing thrombosis has been suggested as a cause of pain. Rarely,lesionsmaybediffusewithinthe liver,594,595 or may even be associated with similar-appearing cavernous haemangiomasinadjacentorgans. This lesion involved the entire right lobe and extends in an irregular manner into the left lobe. Smaller haemangiomatous foci (bottom centre), as well as isolated minute clusters of haemangioma-like vessels represented by multiple small, dot-like foci, are extensive in number within the adjacent liver (right). The vascular spaces in these lesions have the same morphology as those within cavernous haemangioma. The vascular channel walls are composed of an admixture of smooth muscle and fibrous stroma. Haemorrhagic smear shows a compact coil of elongated spindle cells with bland nuclear features. These organizing thrombi could eventually result in extensive scarring over time and the so-called sclerosed haemangioma. In end-stage sclerosed and calcified haemangiomas, an underlying vascular pattern may be a clue to the diagnosis. These highly sclerotic lesions can also contain mast cells, which in turn may play a role in the organizing process. Mostcases are identified in infants younger than 6 months,132,602­604 and this tumour is twice as common in girls as in boys. Surgical resection may not always be possible due to multifocality and large size with extensive arterialization, so othertreatments. A question has been raised as to the true nature of the large lesions associated with large abnormal vessels and cardiac failure or other severe symptoms. This argues against the diagnosis of true infantile haemangioma in at least some of these lesions, suggesting that the large lesions with abnormal large vessels may instead represent vascular malformations with a peripheral capillary reaction.

The histological findings varied medicine 027 pill generic risperidone 3 mg on-line, with extensive necrosis 25 medications to know for nclex best order risperidone, steatosis medications quinapril buy risperidone overnight delivery, steatohepatitis symptoms toxic shock syndrome discount risperidone 3 mg mastercard, lymphocytic inflammatory infiltrates in portal areas and canalicular and hepatocellular cholestasis medicine checker buy risperidone 2 mg otc, but no specific biopsy findings prevailed. The mechanism appears to be metabolic idiosyncrasy, possibly from reactive quinoneimine metabolites,785 with injury occurring 6­28 weeks after the start of therapy. One report of acute hepatitis caused by trazodone cited cholestatic hepatitis on biopsy. Mephenytoin and phenacemide are two agents that were abandoned due to a high incidence of liver failure. The frequent use of multiple drugs in patients whose convulsions are difficult to control complicates incrimination of individual drugs. Phenytoin (diphenyhydantoin) liver injury is well documented, with >100 cases reported. Enzyme elevations are often accompanied by fever, rash, eosinophilia and jaundice. Indeed, in some patients, severe generalized hypersensitivity, rather than hepatic failure per se, appears responsible for the devastating clinical syndrome. In addition, lymphadenopathy with a spectrum of changes from benign to malignant lymphomas799 and bone marrow injury800 may accompany the liver damage. Phenobarbital has been employed as an anticonvulsant since 1918, as well as an anxiolytic agent, and it is a relatively rare cause of hepatic injury despite its widespread use. Among the estimated 250 cases of overt hepatic injury attributed to this drug, cholestatic and hepatocellular injury as well as hepatic granulomas have all been reported. Multiple hepatocellular adenomas occurred in a patient who had been treated with carbamazepine for 14 years. In patients with microvesicular steatosis, the clinical presentation is similar to Reye syndrome, with hepatic failure and acidosis. In the other form of hepatic injury, patients develop hepatocellular or mixed biochemical injury 1­6 months after starting the drug. The syndrome is characterized by somnolence, hyperammonaemia, coma and coagulopathy. Children, and particularly infants <2 years old, are more susceptible than adults. The development of carnitine deficiency after long-term valproate use has been suggested as a possible contributing mechanism. The injury has been hepatocellular, with massive hepatic necrosis seen at autopsy. In one fatal case, a subacute course of progressive liver damage was documented in serial liver biopsies, with an initial biopsy showing approximately 50% hepatocyte necrosis. At autopsy, massive hepatic necrosis with extensive bile duct proliferation was seen. Riluzole, an antiglutamate agent 734 Chapter 12 Drugs and Toxins used in the treatment of amyotrophic lateral sclerosis, has been implicated in three instances of acute hepatitis that all resolved after withdrawal of the drug. As a result, tolcapone was withdrawn from use in Europe, and its use is severely restricted elsewhere. Entacapone has only rarely been linked to hepatic injury,849 and no cases of liver failure have been reported. It should be remembered that the underlying rheumatic disease being treated also may adversely affect the liver, leading at times to diagnostic confusion. Biochemical abnormalities are also seen in Felty syndrome, Sjögren syndrome, progressive systemic sclerosis, polyarteritis nodosa, essential mixed cryoglobulinaemia (which may be associated with chronic hepatitis C), polymyalgia rheumatica, Reiter syndrome and occasionally even osteoarthritis. The phenomenon appears to depend on the salicylate moiety because it has been observed with aspirin, choline salicylate and sodium salicylate. It has been suggested that these pathways are readily saturated in children, as well as adults, leading to the accumulation of an otherwise minor, nontoxic metabolite that may become responsible for hepatic injury. The exact mechanism may involve lipid peroxidation, mitochondrial damage, hydroxyl radical scavenging or injury to hepatocyte membranes. The mechanism by which aspirin causes the microvesicular steatosis associated with Reye syndrome is probably mediated through mitochondrial injury. There are rare reports of injury due to trisalicylate, but biopsy findings have not been reported. Granulomas were rarely found, but a few individuals had changes consistent with chronic hepatitis in the available histological material. A delayed onset of injury (up to 3 months) and a late response to rechallenge suggest metabolic idiosyncrasy, and a reactive metabolite has been postulated. Necrosis may be zonal or massive and may be accompanied by microvesicular steatosis. Bilirubin levels usually remain normal or are only minimally elevated, with overt jaundice in <5% of cases. Liver biopsy characteristically shows areas of spotty necrosis, with a mild inflammatory response in portal areas and mild steatosis. Levels >15 mg/dL can lead to high transaminase levels, hyperbilirubinaemia and biopsy evidence of parenchymal injury in up to 50% of patients. There is marked swelling of hepatocytes with some cytoplasmic vacuolation, as well as mild reactive inflammatory changes with some ceroid-laden macrophages. The half-life of benoxaprofen was prolonged in patients older than 40,887 possibly contributing to the injury seen almost exclusively in elderly patients. Histologically, there was acute (bland) cholestasis with canalicular cholestasis in zone 3 and minimal associated inflammation or apoptosis. Oxaprozin has been associated with rare cases of hepatocellular injury, with acute hepatitis and zonal necrosis on biopsy. Oxicams Piroxicam has led to cases of hepatocellular injury with extensive necrosis, some fatal,900­902 as well as to histological cholestatic hepatitis and acute (bland) cholestasis. Meloxicam has been associated with acute (bland) cholestasis with hepatocellular swelling in one report. Pyrazolone derivatives Phenylbutazone was associated with >100 cases of hepatic injury, with an incidence of overt hepatotoxicity of 1­5%, and jaundice occurred in 0. Oxyphenbutazone apparently produces a similar injury and is also not currently marketed. Rare case reports have appeared incriminating anakinra in cases of acute hepatitis. Rare case reports have shown hepatocellular injury, with acute cholestatic hepatitis in one case928 and zonal necrosis in another. It has been incriminated in at least 20 cases of intrahepatic cholestasis, the mechanism being hypersensitivity. The biochemical changes produced by small, weekly doses of methotrexate taken for psoriatic and rheumatoid arthritis are usually mild and may be misleading in relation to the hepatic damage. Portal inflammation is usually moderate and consists of lymphocytes, macrophages and neutrophils. Many series of arthritic patients monitored for injury have revealed only steatosis and some fibrosis,915,916 although cases of severe hepatic disease have been 738 Chapter 12 Drugs and Toxins hepatocellular injury,940 mixed hepatocellular-cholestatic injury941 and several instances of fulminant hepatic failure. Although nimesulide is a sulphonamide derivative, eosinophilia has been described in a minority of patients, suggesting metabolic idiosyncrasy rather than hypersensitivity as the mechanism. These include minor hepatic dysfunction,22 hepatic granulomas (with or without a fibrin ring),96,948,949 cholestasis and some cases of hepatic necrosis. Dantrolene, which was introduced for the treatment of severe muscle spasm associated with serious neurological disease, can also produce cytotoxic hepatic injury. Zoxazolamine, briefly used as a muscle relaxant several decades ago, produced severe hepatic necrosis in patients, leading to its abandonment. Oral hypoglycaemic drugs Sulphonylureas treat diabetes by increasing secretion of insulin from the pancreas. They are divided into first- and second-generation agents, with the second-generation drugs being more potent. Firstgeneration drugs include acetohexamide, chlorpropamide, tolazamide and tolbutamide. All have been the subject of hepatotoxicity reports, but they have been mainly replaced in clinical use by the secondgeneration drugs. Sulphonylurea derivatives also can produce granulomas in the absence of other evidence of hepatic injury. Glyburide (glibenclamide) has rarely been associated with liver injury that resembles acute or chronic hepatitis. Glimepiride has been implicated in lesions of zonal necrosis as well as varying degrees of cholestatic hepatitis. Although the exact mechanism of injury has not been determined, several theories have been proposed. The mechanism appears to be metabolic idiosyncrasy, possibly related to P-450 or other genetic susceptibilities. A, Medium magnification of portal area with an acute and chronic infiltrate, ductular reaction and dropout of hepatocytes. The sodium glucose co-transporter-2 inhibitors canagliflozin, dapagliflozin and empagliflozin have not been associated with hepatic injury. Thiourea derivatives for thyroid disease There appear to be differences among the types of injury produced by different derivatives of thiourea. The cases of jaundice induced by methimazole, carbimazole and methylthiouracil seem to have been biochemically cholestatic or mixed. Both groups of drugs are intrinsic hepatotoxins capable of producing acute cholestatic jaundice. The presence of an alkyl or ethinyl group in the C-17 position appears to be essential for the production of cholestatic jaundice. In most of the patients who developed jaundice, the drug had been taken for 1­6 months. Death has been reported only in patients who were debilitated or had other disease,116 and the more typical course is prolonged, deep jaundice. Both stilboestrol and diethylstilboestrol appear to have the potential for producing parenchymal injury. The lesions and associated steatohepatitis resolved after discontinuation of the medication. There have been multiple examples of severe hepatic necrosis with fulminant liver failure. There appears be to an increased risk of flutamide liver injury in patients with underlying chronic viral hepatitis. Biopsies have shown acute cholestatic hepatitis, with submassive necrosis at autopsy. Acenocoumarol1055 and warfarin1056,1057 also have been incriminated in instances of cholestatic injury. Cases of acute (sometimes fatal) hepatitis as well as chronic hepatitis have been attributed to phenprocoumon. Unfractionated and low-molecular-weight heparins are associated with a high frequency (up to 80%) of low-level transaminase elevations seen early in the course of therapy. Most have not been in use long enough for postmarketing reports of hepatotoxicity to appear, but rivaroxaban has been rarely associated with liver injury. Cases developed within 8 weeks of starting the drug and showed hepatocellular injury with confluent, coagulative necrosis on biopsy. In most patients, readministration of a single dose of quinidine led to prompt recurrence of fever and elevated transaminase levels. The phospholipidosis that this drug can produce is described earlier, as are the changes simulating alcoholic liver Antihypophyseal drugs Octreotide, an analogue of somatostatin, has been implicated in several cases of hepatocellular injury in adults, children and infants. About 10% of these were accompanied by jaundice, which had both 742 Chapter 12 Drugs and Toxins Table 12. Whereas the pseudoalcoholic changes usually occur in patients with phospholipidosis, they may precede the latter. Indeed, the two lesions may be presumed to be of different pathogenesis, since each may occur independently of the other. Cholestatic jaundice has been reported,1088 presumably caused by immunological idiosyncrasy, as well as a case of microvesicular steatosis. Ajmaline, an alkaloid derived from the root of Rauwolfia serpentina, is closely related to quinidine in structure and has found similar clinical applications. Antihypertensives Methyldopa has led to hepatic injury in hundreds of cases over decades of widespread clinical use. The predominant injury has been hepatocellular, resembling that of acute viral hepatitis. Coombspositive haemolytic anaemia occurs in 3% of patients with hepatic injury, similar to the overall incidence in recipients of methyldopa. Ballooning degeneration, hepatocellular apoptosis and areas of necrosis are characteristic. The inflammatory response tends to be concentrated in the portal and periportal zones. It consists mainly of lymphocytes and other mononuclear cells with some neutrophils. Prominence of plasma cells is also not characteristic of the acute form of injury, but is seen in the patients who develop chronic hepatitis. Bridging necrosis extending between portal areas and from portal to central areas was prominent among the patients of Maddrey and Boitnott,74 and several had severe subacute hepatic necrosis. A chronic syndrome similar to the autoimmune type of chronic hepatitis has been attributed to methyldopa. The inflammatory cells have consisted of lymphocytes, plasma cells and varying numbers of eosinophils. Biopsy specimens from some patients have shown fibrous septum formation, and several have had patterns of frank macronodular cirrhosis in a setting of chronic necroinflammatory disease. Some patients had already developed clinical evidence of cirrhosis when first diagnosed with liver disease. Others presented with apparently acute hepatocellular injury, only to have the biopsy reveal chronic hepatitis.

Buy risperidone 2 mg overnight delivery. Chronic Fatigue Fibromyalgia and Direct Service Connection.

Identification of small cells with oval nuclei in rat models of hepatocarcinogenesis and in regenerative responses to liver injury led to the premise that there is a liver progenitor cell compartment treatment skin cancer risperidone 3 mg purchase with visa. Similar oval cells have been identified in the human liver684 and are capable of differentiating into hepatocytes and cholangiocytes acne natural treatment risperidone 3 mg with visa. Similarities to the ductal plate hepatocytes of the fetal liver suggested that adult progenitor cells reside in the periportal region medicine 6mp medication buy risperidone without prescription,678 symptoms when pregnant generic risperidone 2 mg buy online,685 with extensive attention being given to the canal of Hering:ductular compartment at the portal tract­parenchymal interface medicine game buy 2 mg risperidone. A, Residual parenchyma (left) merges into ductular reaction (middle and right) (H&E stain). B, Higher-power view of region at right, showing ductular reaction at the interface with the region of necrosis and inflammation (top and upper right) (H&E stain). C, Cytokeratin 7 (K7) immunohistochemistry showing variable positivity in the ductular reaction, indicative of differentiation toward cholangiocytes (strong positivity) or hepatocytes (weaker or loss of positivity). In general, abnormal matrix deposition within the space of Disse occurs in those parts of the parenchyma where cell injury and inflammation are greatest. In the past, fibrosis occurring in the course of chronic liver diseases in humans had been viewed as a relentless process that could sometimes be halted, but that would not regress. The therapeutic advances of the last 25 years have shown that fibrosis is a reversible process, at least in those cases with relatively thin fibrous septa (see Evolution of chronic liver diseases, later). Although such progress has mostly resulted from therapies directed at the etiology of each disease. In this schematic the normal sinusoidal microanatomy is depicted on the left, with cirrhotic liver on the right. The sinusoidal channel is bounded by sinusoidal endothelial cells, which normally are fenestrated but lose their fenestrations in the cirrhotic liver. The space of Disse normally contains scattered fat-storing perisinusoidal stellate cells; these proliferate and become myofibroblasts in the cirrhotic liver. There are normally only delicate reticular collagen fibrils in the space of Disse. Activated myofibroblastic stellate cells are the primary source of fibrillar collagen and other extracellular matrix proteins that are deposited in the space of Disse. Notably, a basal lamina is deposited under the nonfenestrated endothelial cells, completing the process of capillarization. The major parenchymal source of excess collagen under abnormal conditions is stellate cells. Inflammatory activation of Kupffer cells leads to secretion of multiple cytokines; cytokines may also be released by endothelial cells, hepatocytes and other inflammatory cells of the innate immune system within the liver, such as T lymphocytes (not shown). Stellate cell involution represents a critical step in the process of regression of fibrosis in patients with chronic liver diseases undergoing treatment. Perivenular sinusoidal fibrosis has been well documented in the early stages of liver injury from alcohol737­739 or toxins740 in both animals and humans. This is accompanied by a decrease in sinusoidal density in the perivenular region. Increasing attention is directed to fibroblasts located in portal tracts, both encircling bile ducts and ductules, and elsewhere in portal tracts. Whereas the portal vein and hepatic artery have walls composed of smooth muscle cells, the cholangiocytes reside on a basement membrane surrounded directly by periductular fibroblasts. The interface between portal tract with its hepatic artery (left) and the parenchyma (right) is indistinct. There are abundant, strongly staining, activated portal tract myofibroblasts and sinusoidal stellate cells. The myofibroblasts of bridging septa in cholestatic fibrotic livers strongly resemble the myofibroblasts of the portal field,752 suggesting that portal tract myofibroblasts migrate into the developing parenchymal septa. Regardless, these phenotypic data suggest a mechanism whereby portal fibroblasts play the dominant role in biliary fibrosis. These include myofibroblasts loosely placed around the portal vein and hepatic artery and those in the loose connective tissue of the portal field, especially at the interface between the portal tract and parenchyma. These enzymes are synthesized as a preproenzyme, which is then activated by proteinases. The activated enzyme cleaves type I collagen at specific Gly­Ile and Gly­Leu bonds. The enzyme has been identified in Kupffer cells and is released on their activation. The potential role of this group of proteases in regulating the intrahepatic balance between fibrogenesis and fibrolysis is increasingly recognized. Regulation of gene expression is influenced by the same growth factors and cytokines that are involved in the regulation of metalloproteinase gene expression. The biochemical correlates are that intrahepatic collagenase activity seems to be greatest during the development of early and progressive fibrosis, but diminishes with advanced fibrosis. With progressive fibrosis, the diameter of residual endothelial fenestrations slightly decreases, but the overall area porosity drops to below 0. Vascular thrombosis the second vascular insult in chronic liver damage is thrombosis. Portal vein lesions were associated with prominent regional variation in the size of cirrhotic nodules. Hepatic vein lesions were associated with regions of confluent fibrosis and parenchymal extinction. Regardless, a prothrombotic environment, with accumulation of fibrin and platelet microthrombi within the hepatic circulation, is therefore established. First, sclerosis of the portal tracts and their vascular branches increases presinusoidal vascular resistance. Fibrosis in the perivenular region of the lobule may partially obstruct vascular outflow, creating postsinusoidal vascular resistance. Second, with the formation of bona fide bridging fibrous septa between portal tracts and terminal hepatic veins, portovenous and arteriovenous shunting occurs. A, the normal microanatomy of the liver is depicted, showing especially the channels for flow of portal venous blood through the sinusoids of the parenchyma, and normal sinusoidal architecture. Abnormal arteriovenous shunts and vascular shunts from portal to hepatic veins develop. Perisinusoidal stellate cells lose their fat stores, proliferate and develop a myofibroblast phenotype. Both populations of cells deposit extracellular matrix, expanding portal tracts and the space of Disse, respectively. A, the normal anatomy is depicted, showing sinusoidal channels emanating from portal vein tributaries (venules) and directly from the portal vein. The hepatic artery primarily feeds the peribiliary capillary plexus, vasa vasorum of both portal vein and terminal hepatic vein, and the hepatic capsule. B, In the cirrhotic liver, portal tract extracellular matrix is increased, with sclerosis around portal veins and other structures leading to increased presinusoidal vascular resistance. Abnormal hepatic artery-to-portal vein shunts contribute to increased portal vein pressure. While portal vein-derived venules persist for perfusion of the parenchyma, the sinusoids have lost their fenestrated endothelium and develop a basal lamina with fibrosis in the space of Disse, leading to increased sinusoidal resistance. Concomitantly, abnormal septal vasculature has developed with portal vein-to-terminal hepatic vein and hepatic artery-to-terminal hepatic vein shunting, effectively bypassing the parenchyma. Sclerosis around the terminal hepatic vein increases postsinusoidal resistance, impeding outflow of sinusoidal blood and further promoting shunting of blood around the parenchyma. Interestingly, sinusoids within the cirrhotic nodules may retain much of their normal ultrastructural architecture844; they are just not adequately perfused. Angiogenesis: arterial and venous changes Physiological hepatic angiogenesis-the formation of new blood vessels-occurs during liver regeneration, leading to the formation of new functional sinusoids. Zonation An underappreciated physiological change in the damaged liver is an alteration in the zonal distribution of hepatocellular metabolism. Experimental studies in the rat have shown that the changes in the vascular architecture of the liver and in the hepatocyte microenvironment induced by liver fibrosis do indeed result in alterations of the metabolic organization of the hepatic parenchyma. However, glutamine synthetase is undetectable in cirrhotic nodules and hepatocyte clusters isolated in fibrous septa, regardless of the aetiology of cirrhosis. Moreover, these findings concur with the lack of terminal hepatic veins in the parenchymal nodules of cirrhosis, again suggesting that the centre of nodules is not an efferent zone (despite the prominence of vascular channels at nodule centres). Conversely, in this study of human livers at least, the periphery of cirrhotic nodules cannot be considered to be homologous to the periportal zone. Thus, profound alterations appear to occur in the metabolic zonation of parenchymal nodules in the cirrhotic liver, but absolute loss of metabolic function does not necessarily occur. Hepatocytes trapped in nodules or in fibrous septa retain most of their enzymatic activities and maintain their capacity for protein synthesis. The regulation of zonal enzyme expression in evolving liver injury in regard to Wnt/-catenin signalling has not yet been explored. Since normal zonation of the mammalian hepatic lobule is thought to enable the liver to perform simultaneously both anabolic and catabolic activities and to respond quickly to alterations in physiological status, 890­892 derangement of such zonation may contribute to the pathogenesis of the metabolic disorders associated with advanced liver disease. Evolution of chronic liver diseases Progression and regression Each chronic liver disease has a distinctive natural history that depends on aetiology, host responses and environmental factors. As discussed earlier, fibrosis (scarring) is a key factor in disease progression; in association with hepatocyte loss, fibrosis can lead to significant architectural distortion over time. It was previously believed that fibrosis might stabilize over time but could not regress. It has now become clear, in a variety of chronic liver diseases, that fibrosis may regress after successful treatment. To summarize the many concepts presented in this chapter, and using histology as the frame of reference, the disease activity of viral hepatitis manifests as foci of spotty necrosis (scattered foci of necroinflammatory activity in the lobules), interface hepatitis (damaging the limiting plates) and in severe cases, confluent necrosis and bridging necrosis. Kupffer cell activation and lymphocytic infiltration play the major roles in the elimination of infected hepatocytes. Over time, periportal fibrous septa may link adjacent portal tracts, while bridging necrosis may evolve to bridging fibrosis linking terminal hepatic (central) veins and portal tracts. Progressive hepatocyte loss, scarring and regeneration lead to architectural distortion, characteristic of the advanced stages of chronic viral hepatitis. Plasma cells are usually prominent in the inflammatory infiltrates of autoimmune hepatitis. Interface hepatitis and confluent/bringing necrosis are often severe in this condition and can cause significant parenchymal loss, scarring and architectural distortion over months to a few years. Fatty liver diseases are characterized by steatosis, hepatocyte injury (evidenced by ballooning degeneration, Mallory­Denk bodies and megamitochondria) and chronic inflammation. There is a spectrum of patterns of fibrosis in fatty liver diseases, most often originating as perisinusoidal­perivenular­pericellular fibrosis, then evolving to formation of central­portal fibrous septa dissecting the hepatic lobules, and finally culminating in micronodular cirrhosis. Venesection may lead to significant improvement of fibrosis in patients with haemochromatosis of advanced stages; regression of cirrhosis has also been reported. A portal-based pattern of fibrosis is characteristic of these conditions and is not known to regress over time. Severe passive congestion of the liver, as seen in Budd­Chiari syndrome, can cause significant hepatocyte loss and fibrosis, leading to cirrhosis. The required elements of fibrous septa and parenchymal architectural disturbances each occur in a spectrum, from minimal to severe. First, the architecture of the entire liver is disrupted by interconnecting fibrous scars. Second, the fibrous scars may be present in the form of delicate bands connecting portal tracts and centrilobular terminal hepatic veins in a portal-to-portal, portal-to-central, and/or central-to-central pattern, or may be present as broad fibrous tracts obliterating multiple adjacent lobules. Third, parenchymal nodules are created by fibrotic isolation of islands of hepatic parenchyma. The nodules may vary from micronodules (<3 mm in diameter) to macronodules (3 mm to several centimetres in diameter). First, fibrous subdivision of the liver parenchyma into isolated islands is a requisite for the diagnosis; regeneration of these islands is not. Thus, fibrosis which evolves rapidly over several months may still produce a cirrhotic organ, even if there is insufficient time for substantive expansion of the islands into spherical nodules by regeneration. Second, the normal parenchymal distance from portal tract to terminal hepatic vein is Cirrhosis the previous brief presentation of chronic liver disease evolution indicates that, despite differences in etiology and pathogenesis, some common histological features characterize the advanced stages of these conditions, including chronic inflammation, scarring and architectural distortion. If left untreated, chronic liver diseases often evolve to their end stages, which are characterized by profound histological changes and clinical deterioration, including hepatic failure and portal hypertension with serious complications (ascites, variceal haemorrhage, hepatic encephalopathy). In 1977 an international panel sponsored by the World Health Organization defined cirrhosis as a diffuse process characterized by fibrosis and the conversion of normal liver architecture into structurally abnormal nodules. Although the heterogeneity of cirrhosis, reflecting a variety of aetiologies (Table 1. However, the hepatic capacity for regeneration is enormous, and parenchymal regeneration in the face of more slowly developing fibrosis may produce nodules several centimetres in diameter. Portal tract-based fibrosis may produce a much more coarsely subdivided and irregular cirrhotic liver. Occasionally, a severe focal injury to the liver results in changes histologically indistinguishable from cirrhosis on percutaneous needle biopsy; this focal change is not considered true cirrhosis. When this question arises, having definitive information from clinical evaluation and imaging studies on the general status of the liver, or a biopsy sample from elsewhere in the liver, is critical to determining whether a fibrotic process is focal or diffuse. Because of the qualitative nature of the definition for cirrhosis, the point at which a liver with chronic hepatitis and fibrous scarring is designated as truly cirrhotic is arbitrary and cannot easily be established on percutaneous needle biopsy tissue (which represents <1/10,000th of the liver mass). Fortunately, clinical data provide valuable guidance on whether abnormal findings observed in percutaneous liver biopsy tissue are representative of the whole liver. Laboratory data may not reveal abnormalities, in that serum levels for albumin, clotting factors, urea, alkaline phosphatase, transaminases and bilirubin may be normal in a patient who has quiescent cirrhosis with minimal ongoing damage and who has not yet developed hepatic failure. Conversely, a patient with massive hepatic necrosis and hepatic failure is not cirrhotic, despite profound abnormalities in serum parameters.

References

• Pessin MS, Duncan GW, Mohr JP, et al. Clinical and angiographic features of carotid transient ischemic attacks. N Engl J Med 1977;296:358-62.
• Wilson RD, Hedrick HL, Liechty KW, et al. Cystic adenomatoid malformation of the lung: review of genetics, prenatal diagnosis, and in utero treatment. Am J Med Genet 2006; 140A:151-5.
• McCune J: The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410: 974, 2001.
• Bowman FO, Malm JR, Hayes CJ, et al. Pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg. 1971;61:85-93.
• Thienhaus, O., & Cole, B. E. (1998). The classification of pain. In Weiner, R. S. (Ed.), Pain management: A practical guide for clinicians (5th ed., pp. 19n26). Boca Raton, FL: CRC Press. Thienhaus, O., & Cole, B. E. (2001). The classification of pain. In R. S. Weiner (Ed.), Pain management: A practical guide for clinicians (6th ed., pp. 27n36). Boca Raton, FL: CRC Press. Waldman, S. D. (2002). Atlas of common pain syndromes. Philadelphia: W.B. Saunders. Waldman, S. D. (2003). Atlas of uncommon pain syndromes. Philadelphia: W.B. Saunders. Waxman, S. G. (2001). Form and function in the brain and spinal cord: Perspectives of a neurologist. Cambridge, MA: MIT Press. Waxman, S. G. et al. (2001). Sodium channels and pain. In S. G. Waxman (Ed.), Form and function in the brain and spinal cord: Perspectives of a neurologist (pp. 421n431). Cambridge, MA: MIT Press. Woessner, J. (2002a). A conceptual model of pain. Practical Pain Management, 2(5), 8n16, 37.
• Bowne WB, Julliard K, Castro AE, et al: Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: A prospective, comparative analysis. Arch Surg 141:683, 2006.